← Back to Search

SIESTA Rehab Education for Stroke Recovery

N/A
Waitlist Available
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights

Study Summary

This trial will test whether the SIESTA-Rehab intervention leads to better sleep and improved recovery for stroke patients during acute rehabilitation.

Who is the study for?
This trial is for adults over 18 who've had a stroke and are admitted to the Shirley Ryan AbilityLab. They must be able to consent, follow study procedures, and have medical clearance. It's not for those with serious heart conditions, neurological diseases like MS or Alzheimer's, pregnant/nursing women, people with skin allergies/open wounds, or users of certain cardiac devices.Check my eligibility
What is being tested?
The SIESTA program aims to improve sleep during acute stroke rehabilitation by educating nurses on minimizing disruptions and using a protocol called ApneaLink to screen and treat sleep-disordered breathing if it occurs.See study design
What are the potential side effects?
Since this trial focuses on education and screening protocols rather than medications or invasive treatments, side effects may be minimal but could include discomfort from wearing the ApneaLink device for sleep monitoring.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in total sleep time as measured by Actigraphy
Karolinska Sleep Diary
Modified Potential Disruptions of Hospital Sleep Questionnaire (PDHSQ)
+1 more
Secondary outcome measures
10-Meter Walk Test (10MWT)
6-Minute Walk Test with VO2 analysis (6MWT)
Apnea Hypopnea Index (AHI)
+13 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SIESTA RehabExperimental Treatment2 Interventions
Stroke floor on which nurses will be receiving training (SIESTA Rehab Education) on how to minimize nighttime disruptions and batching overnight tasks to preserve sleep for patients hospitalized on that floor. Stroke patients admitted to the SIESTA Rehab Unit will be screening for sleep disordered breathing using ApneaLink. Patients hospitalized on this unit will be approached for consent to wear sensors and actigraphy watches during the hospital stay and after discharge.
Group II: Control UnitActive Control1 Intervention
Patients on this unit will receive usual care for stroke patients as outlined by SRALab. including routine nursing care without any intervention to promote sleep like SIESTA and routing sleep disorders screenings based on clinician judgement. Patients hospitalized on this unit will also be approached for consent to wear sensors and actigraphy watches during the hospital stay and after discharge.

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
1,004 Previous Clinical Trials
819,377 Total Patients Enrolled
9 Trials studying Stroke
3,250 Patients Enrolled for Stroke
Shirley Ryan AbilityLabOTHER
194 Previous Clinical Trials
16,512 Total Patients Enrolled
70 Trials studying Stroke
7,945 Patients Enrolled for Stroke
Northwestern UniversityOTHER
1,589 Previous Clinical Trials
916,687 Total Patients Enrolled
30 Trials studying Stroke
24,805 Patients Enrolled for Stroke

Media Library

SIESTA Rehab Education Clinical Trial Eligibility Overview. Trial Name: NCT04254484 — N/A
Stroke Research Study Groups: SIESTA Rehab, Control Unit
Stroke Clinical Trial 2023: SIESTA Rehab Education Highlights & Side Effects. Trial Name: NCT04254484 — N/A
SIESTA Rehab Education 2023 Treatment Timeline for Medical Study. Trial Name: NCT04254484 — N/A
Stroke Patient Testimony for trial: Trial Name: NCT04254484 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the primary objective of this experiment?

"This inpatient trial seeks to quantify changes in sleep duration with secondary objectives of analysing 6-Minute Walk Test results, evaluating functional balance with the Berg Balance Scale, and monitoring mobility via activity counts. Patients are expected to stay for an average of 17 days while undergoing continuous observation."

Answered by AI

Are there any available openings to participate in this research?

"Per clinicaltrials.gov, this particular study has stopped recruiting patients since it was last updated on August 18th 2022; however, there are currently over 1400 other medical trials that are presently seeking candidates for participation."

Answered by AI

Who else is applying?

What state do they live in?
Illinois
What site did they apply to?
Shirley Ryan AbilityLab
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I can not sleep good. I wakeup in the middle of the night and can not breathe good.
PatientReceived no prior treatments

What questions have other patients asked about this trial?

I would like to know how long is the trial and if it is in a location or I could do in my house?
PatientReceived 1 prior treatment
~46 spots leftby Nov 2024